Acting on Imperfect Evidence: How Much Regret Are We Ready to Accept?
- 1 October 2005
- journal article
- editorial
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 23 (28) , 6822-6825
- https://doi.org/10.1200/jco.2005.06.007
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Impact of Five Prophylactic Filgrastim Schedules on Hematologic Toxicity in Early Breast Cancer Patients Treated With Epirubicin and CyclophosphamideJournal of Clinical Oncology, 2005
- Colony-Stimulating Factors for Chemotherapy-Induced Febrile Neutropenia: A Meta-Analysis of Randomized Controlled TrialsJournal of Clinical Oncology, 2005
- Standards of Proof, Standards of Practice, and Proof of Standards: A Tale of Two TrialsJournal of Clinical Oncology, 2005
- Well informed uncertainties about the effects of treatmentsBMJ, 2004
- Addition of Either Lonidamine or Granulocyte Colony-Stimulating Factor Does Not Improve Survival in Early Breast Cancer Patients Treated With High-Dose Epirubicin and CyclophosphamideJournal of Clinical Oncology, 2003
- Randomized Trial of Dose-Dense Versus Conventionally Scheduled and Sequential Versus Concurrent Combination Chemotherapy as Postoperative Adjuvant Treatment of Node-Positive Primary Breast Cancer: First Report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741Journal of Clinical Oncology, 2003
- Acceptable regret in medical decision makingMedical Hypotheses, 1999
- Recombinant granulocyte colony stimulating factor reduces the infectious complications of cytotoxic chemotherapyEuropean Journal Of Cancer, 1993
- Reduction by Granulocyte Colony-Stimulating Factor of Fever and Neutropenia Induced by Chemotherapy in Patients with Small-Cell Lung CancerNew England Journal of Medicine, 1991
- The 'Chagrin Factor' and Qualitative Decision AnalysisArchives of internal medicine (1960), 1985